documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

7 rows where docket_id = "FDA-2004-E-0201" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: title, subtype, posted_month, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

posted_year 4

document_type 3

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2004-E-0201-0007 FDA Patent Extension for HUMIRA (adalimumab), U.S. Patent No. 6,090,382 FDA-2004-E-0201 Certificate Extending Patent Term from U.S. Patent and Trademark Office to Abbott Laboratories Rule Certificate Extending Patent Term 2007-04-23T04:00:00Z 2007 4     2025-11-20T20:27:44Z   0 0 0900006480470be6
FDA-2004-E-0201-0006 FDA Patent Extension for HUMIRA (adalimumab), U.S. Patent No. 6,090,382 FDA-2004-E-0201 Letter from FDA CDER to U.S. Patent and Trademark Office Other Letter(s) 2006-09-08T04:00:00Z 2006 9     2025-11-20T20:26:20Z   0 0 0900006480470be5
FDA-2004-E-0201-0005 FDA Patent Extension for HUMIRA (adalimumab), U.S. Patent No. 6,090,382 FDA-2004-E-0201 Letter from U.S. Patent and Trademark Office to FDA CDER Other Letter(s) 2006-06-19T04:00:00Z 2006 6     2025-11-20T20:24:41Z   0 0 0900006480470be4
FDA-2004-E-0201-0004 FDA Patent Extension for HUMIRA (adalimumab), U.S. Patent No. 6,090,382 FDA-2004-E-0201 Determination of Regulatory Review Period for Purposes of Patent Extension; HUMIRA Notice General Notice 2006-02-02T05:00:00Z 2006 2 2006-01-31T05:00:00Z 2006-04-04T03:59:59Z 2025-11-20T20:20:10Z   0 0 0900006480470be2
FDA-2004-E-0201-0003 FDA Patent Extension for HUMIRA (adalimumab), U.S. Patent No. 6,090,382 FDA-2004-E-0201 Letter from FDA CDER to U.S. Patent and Trademark Office Other Letter(s) 2006-01-11T05:00:00Z 2006 1     2025-11-20T20:16:03Z   0 0 0900006480470be1
FDA-2004-E-0201-0002 FDA Patent Extension for HUMIRA (adalimumab), U.S. Patent No. 6,090,382 FDA-2004-E-0201 Letter from FDA CDER to U.S. Patent and Trademark Office Other Letter(s) 2005-04-19T04:00:00Z 2005 4     2025-11-20T19:53:11Z   0 0 0900006480470be0
FDA-2004-E-0201-0001 FDA Patent Extension for HUMIRA (adalimumab), U.S. Patent No. 6,090,382 FDA-2004-E-0201 Letter from U.S. Patent and Trademark Office to FDA CDER Other Letter(s) 2004-09-28T04:00:00Z 2004 9     2025-11-20T19:51:39Z   0 0 0900006480470bdd

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;